They said the deal is awaiting antitrust approval. Both parties and the antitrust body have declined to comment.
This would be Penta Investments’ third acquisition on the Romanian market after acquiring 13 Arta pharmacies in 2017 for an estimated EUR5-10 million, and A&D Pharma in 2018, which includes Sensiblu pharmacies and wholesaler Mediplus, for an estimated EUR300-400 million.